Filing Flows › United Guardian (UG) › Pharmaceuticals revenue
United Guardian (UG) Pharmaceuticals revenue by quarter
United Guardian's Pharmaceuticals revenue was $1.5M in Q2 2026 (second quarter 2026), +2% from Q1 2026. Over the last 5 quarters it ranged from $1.2M (Q1 2025) to $1.5M (Q2 2026).
| Quarter | Pharmaceuticals revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.5M | +2% | +1% |
| Q1 2026 | $1.4M | +17% | +24% |
| Q3 2025 | $1.2M | -15% | — |
| Q2 2025 | $1.5M | +24% | — |
| Q1 2025 | $1.2M | — | — |
Q2 2026 at a glance
United Guardian, Q2 2026: revenue $3.1M (+10% year over year), operating margin 24.3%, net earnings $729K, operating cash flow $1.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is United Guardian's Pharmaceuticals revenue?
United Guardian's Pharmaceuticals revenue was $1.5M in Q2 2026 (second quarter 2026), +2% from Q1 2026.
How has United Guardian's Pharmaceuticals revenue changed?
Over the last 5 quarters it ranged from $1.2M (Q1 2025) to $1.5M (Q2 2026).